Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1988-11-3
|
pubmed:abstractText |
Haemophilus influenzae type B vaccine is recommended for children 1.5 to 6 years of age with sickle cell anemia, but the adequacy of their response is unknown. A total of 69 children with sickle cell syndromes, 1.5 to 5.6 years of age, were immunized with two vaccines alternatively, single blind. PRP vaccine was given to 36 children and a diphtheria toxoid conjugated vaccine, PRP-D, was given to 36. Coded pre- and postvaccine sera were tested by radioimmunoassay for anti-PRP antibody. The groups did not differ in age distribution or type of sickle hemoglobinopathy. Preexisting antibody levels were low in both vaccine groups; 65% were less than 0.15 microgram/mL. The vaccines were safe but associated with frequent minor reactions. PRP-D gave higher geometric mean titers and mean fold titer increase than PRP in all children (15.58 micrograms/mL [234-fold] v 2.63 micrograms/mL [29-fold]) and in the subgroups 1.5 to 2.5 years of age or with pretiter values less than 0.15 microgram/mL. Titers for 64% of children receiving PRP and 94% receiving PRP-D were greater than or equal to 1.0 microgram/mL. Thus, both vaccines were useful in this population, but PRP-D was more immunogenic. Duration of antibody levels postvaccination, booster responses, and PRP-D immunogenicity in younger children with sickle cell syndromes all require further study.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Capsules,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Diphtheria Toxoid,
http://linkedlifedata.com/resource/pubmed/chemical/Haemophilus Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Haemophilus influenzae type b...,
http://linkedlifedata.com/resource/pubmed/chemical/Haemophilus influenzae type...,
http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides, Bacterial
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0031-4005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
571-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:3262857-Antibody Formation,
pubmed-meshheading:3262857-Bacterial Capsules,
pubmed-meshheading:3262857-Bacterial Vaccines,
pubmed-meshheading:3262857-Child, Preschool,
pubmed-meshheading:3262857-Diphtheria Toxoid,
pubmed-meshheading:3262857-Haemophilus Vaccines,
pubmed-meshheading:3262857-Haemophilus influenzae,
pubmed-meshheading:3262857-Hemoglobinopathies,
pubmed-meshheading:3262857-Humans,
pubmed-meshheading:3262857-Infant,
pubmed-meshheading:3262857-Polysaccharides, Bacterial
|
pubmed:year |
1988
|
pubmed:articleTitle |
Haemophilus influenzae type b immunization of children with sickle cell diseases.
|
pubmed:affiliation |
Department of Pediatrics, University of Illinois, College of Medicine, Chicago 60612.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|